References
- Barritt DW, Jordan SC: Anticoagulant drugs in the treatment of pulmonary embolism: A controlled trial. Lancet 1:1309–1312, 1960
- Martyn DT, Janes JM: Continuous intravenous administration of heparin. Mayo Clin Proc 46:347–351, May 1971
- Gurewich V, Thomas DP, Stuart RK: Some guidelines for heparin therapy of venous thromboembolic disease. JAMA 199:116–118, 1967
- Genton E: Guidelines for heparin therapy. Ann Intern Med 80:77–82, 1974
- Deykin D: Current concepts: The use of heparin. N Engl J Med 280:937–938, 1969
- Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. Ed 5. New York, Macmillan Publishing Co, Inc, 1975, p 1351
- Gallus AS, Hirsh J, Tutle RJ, et al: Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545–551, 1973
- Gurewich V, Thomas D, Stein M, et al: Bronchoconstriction in the presence of pulmonary embolism. Circulation 27:339–345, 1963
- Salzman EW, Deykin D, Shapiro RM, et al: Management of heparin therapy: Controlled prospective trial, N Engl J Med 292:1046–1050, 1975
- De Takats G: Heparin tolerance: A test of the clotting mechanism. Surg Gynecol Obstet 77:31–39, 1943
- Swanson M, Cacace L: Heparin therapy by continuous intravenous infusion. Am J Hosp Pharm 28:792–795, 1971
- Basu D, Gallus A, Hirsh J, et al: A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 287:324–327, 1972